The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, represents a complex several-stage organic process. Early routes focused on protein portion coupling, utilizing solid-phase creation methodologies to build the long protein sequence. Subsequent research has explored various approaches, including enzymatic… Read More